Need help finding what you are looking for?
Contact Us
PUBLISHER: Visiongain | PRODUCT CODE: 2037277
PUBLISHER: Visiongain | PRODUCT CODE: 2037277
Global Decentralised Clinical Trials Market Report 2026-2036
PUBLISHED:
PAGES: 385 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global decentralised clinical trials market is projected to grow at a CAGR of 7.6% by 2036.
Visiongain has released its latest report, Decentralised Clinical Trials Market Report 2026-2036, delivering a thorough examination of the global decentralised clinical trials market, covering market sizing, demand drivers, competitive dynamics, and revenue projections across core technologies, therapeutic indications, and end-user segments.
The global decentralised clinical trials market is forecast to expand from US$11.3bn in 2026 to US$33.5bn by 2036, at a CAGR of 11.5%, representing a near-tripling of market value over the forecast window as decentralised models become a standard feature of mainstream clinical development.
This expansion is underpinned by continued progress in digital health technology, growing uptake of patient-centric and hybrid trial designs, and increasing reliance on remote monitoring and real-time data capture to improve both trial efficiency and participant engagement.
Digital Innovation Reshaping the Competitive Landscape
Rapid advances in digital health technologies are transforming how decentralised clinical trials are designed and executed. Wearables, mobile health platforms, and cloud-based infrastructure are enabling continuous, real-time data collection - reducing dependence on traditional site-based assessments and improving trial scalability.
Meanwhile, the integration of AI and advanced analytics is supporting predictive monitoring and adaptive trial design, helping sponsors improve data quality, compress development timelines, and sharpen decision-making across clinical programmes.
Trade Flows, Policy Shifts & Supply Chain Pressures
- Global trade conditions, regulatory environments, and geopolitical developments are increasingly shaping the decentralised clinical trials market.
- The sector relies heavily on connected medical devices, sensors, and digital infrastructure - creating exposure to tariffs, export controls, and regulatory variation across key regions.
- Recent tariff measures on electronics and medical components have pushed up the cost of trial-enabling technologies, placing pressure on sponsors and contract research organisations and contributing to broader cost uncertainty.
- In regulated sectors such as pharmaceuticals, adherence to data protection frameworks including GDPR and HIPAA, alongside evolving approval pathways and policy decisions, continues to shape market access and operational execution.
Commercial Implications
- Cost and pricing pressure: Rising device, technology, and compliance costs are straining trial budgets
- Supply chain shifts: Organisations are diversifying sourcing and building more resilient digital infrastructure
- Regulatory influence: Evolving global compliance requirements continue to shape market timelines and access
- Competitive positioning: Companies aligned with digital innovation and regulatory standards are better placed to win
Company Intelligence
The decentralised clinical trials market brings together established technology vendors, contract research organisations, and emerging digital health platforms competing across innovation, scalability, and regulatory capability.
Leading players including Medable, Science 37, IQVIA, and Parexel are reinforcing their positions through platform development, strategic partnerships, and expansion into hybrid and fully decentralised trial models.
Competitive differentiation is increasingly driven by:
- Technology platform capability and integration
- Regulatory and data compliance expertise
- Global operational reach and scalability
- Ability to support hybrid and patient-centric trial models
Newer entrants and specialist providers are also gaining traction where digital agility, flexibility, or cost advantages create meaningful differentiation.
This report examines how competitive positioning is shifting, pinpointing where value is being created and how strategies are expected to evolve across the forecast period.
Key Questions Answered
- What is the projected size of the decentralised clinical trials market by 2036?
- Which segments and regions will drive growth?
- How will digital health technologies and hybrid models shape market evolution?
- How will trade, policy, and supply chain dynamics impact costs and deployment?
- Who are the leading companies and how will their positions evolve?
Report Scope and Data Coverage
- Global decentralised clinical trials market analysis
- Revenue forecasts to 2036
- Segment-level modelling across study design, indication, technology, and end user
- Regional and national market forecasts
- Competitive intelligence on leading companies
Covers both quantitative forecasting and qualitative strategic analysis across technology, competition, policy, and supply chain dimensions.
Segmentation Framework
By Study Design
- Observational
- Interventional
- Expanded Access
By Indication
- Oncology
- Cardiovascular
- Immunology
- Respiratory
- Others
By Technology
- Telemedicine
- Mobile Healthcare
- Wearable Devices
- Web-Based
- Others
By End-user
- Pharmaceutical & Biopharmaceutical Companies
- Clinical Research Organisations
- Others
Geographic Coverage
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Poland
- Belgium
- Switzerland
- Netherlands
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Singapore
- Taiwan
- New Zealand
- Malaysia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Egypt
- Rest of Middle East & Africa
Company Intelligence Coverage
This report includes detailed profiles of leading companies such as:
- 4G Clinical
- Advarra Inc.
- Clario
- ICON PLC
- IQVIA Inc.
- Medable, Inc.
- Oracle Corporation
- Parexel International Corporation
- Science 37
- Veeva Systems
Each profile includes:
- Business overview
- Financial and market positioning
- Product and technology capabilities
- Strategic outlook
Bespoke Intelligence & Customisation
Visiongain also provides tailored intelligence and advisory support aligned to specific client requirements.
This includes:
- Custom market segmentation and forecasts
- Competitive benchmarking and strategy analysis
- Policy and regulatory impact assessment
- Supply chain and sourcing intelligence
- Scenario modelling including tariffs and geopolitical risk
Why This Market Intelligence Matters
- The decentralised clinical trials market is changing rapidly, driven by digital transformation, regulatory evolution, and a fundamental shift in clinical development models.
- Organisations that understand these dynamics will be better placed to capture growth opportunities, manage risk, and sharpen their competitive positioning.
Product Code: PHA1386
Table of Contents
1 Report Overview
- 1.1 Objectives of the Study
- 1.2 Introduction to Decentralised Clinical Trials Market
- 1.3 What This Report Delivers
- 1.4 Why You Should Read This Report
- 1.5 Key Questions Answered by This Analytical Report
- 1.6 Who is This Report for?
- 1.7 Methodology
- 1.7.1 Market Definitions
- 1.7.2 Market Evaluation & Forecasting Methodology
- 1.7.3 Data Validation
- 1.7.3.1 Primary Research
- 1.7.3.2 Secondary Research
- 1.8 Frequently Asked Questions (FAQs)
- 1.9 Associated Visiongain Reports
- 1.10 About Visiongain
2 Executive Summary
3 Market Overview
- 3.1 Key Findings
- 3.2 Market Dynamics
- 3.3 Impact Analysis
- 3.3.1 Market Driving Factors
- 3.3.1.1 Advancements in Digital Health Technologies
- 3.3.1.2 Globalisation of Clinical Trials
- 3.3.1.3 Patient-Centric and Hybrid Trial Models Accelerating Adoption of Decentralised Clinical Trials
- 3.3.1.4 Evolving Regulatory Support and Guidance
- 3.3.2 Market Restraining Factors
- 3.3.2.1 Data Privacy and Security Concerns
- 3.3.2.2 Technological Limitations and Standardization
- 3.3.2.3 Infrastructure and Resource Constraints
- 3.3.3 Market Opportunities
- 3.3.3.1 Acceleration of Drug Development and Innovation
- 3.3.3.2 Expansion of Clinical Trial Activities into Emerging Markets
- 3.3.3.3 Increasing Partnerships and Collaborations Between Pharmaceutical Companies
- 3.3.1 Market Driving Factors
- 3.4 U.S. Tariffs: What's the Impact on Global Decentralised Clinical Trials Market?
- 3.4.1 Overview
- 3.4.2 V-Shaped Recovery Scenario
- 3.4.2.1 Why V-Shaped Recovery?
- 3.4.2.2 Impact from Tariffs
- 3.4.2.3 Market Dynamics and Demand Recovery
- 3.4.2.4 Policy and Funding Support
- 3.4.2.5 Timeframe for Recovery
- 3.4.3 U-Shaped Recovery Scenario
- 3.4.3.1 Why U-Shaped Recovery?
- 3.4.3.2 Impact from Tariffs
- 3.4.3.3 Market Dynamics and Demand Recovery
- 3.4.3.4 Policy and Funding Support
- 3.4.3.5 Timeframe for Recovery
- 3.4.4 L Shaped Recovery Scenario
- 3.4.4.1 Why L-Shaped Recovery?
- 3.4.4.2 Impact from Tariffs
- 3.4.4.3 Market Dynamics and Demand Recovery
- 3.4.4.4 Policy and Funding Support
- 3.4.4.5 Timeframe for Recovery
- 3.4.5 What Strategic Considerations Should Clients Factor into Their Near-term (2025-2030) and Long-term (2025-2035) Planning?
- 3.4.6 Impact of U.S. and China Trade War on Decentralised Clinical Trials Market
- 3.4.7 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
- 3.5 Porter's Five Forces Analysis
- 3.5.1 Bargaining Power of Suppliers
- 3.5.2 Bargaining Power of Buyers
- 3.5.3 Competitive Rivalry
- 3.5.4 Threat of Substitutes
- 3.5.5 Threat of New Entrants
- 3.6 PEST Analysis
4 Decentralised Clinical Trials Market Analysis by Study Design
- 4.1 Key Findings
- 4.2 Study Design Segment: Market Attractiveness Index
- 4.3 Decentralised Clinical Trials Market Size Estimation and Forecast by Study Design
- 4.4 Interventional
- 4.4.1 Market Size by Region, 2026-2036 (US$ Billion)
- 4.4.2 Market Share by Region, 2026 & 2036 (%)
- 4.5 Observational
- 4.5.1 Market Size by Region, 2026-2036 (US$ Billion)
- 4.5.2 Market Share by Region, 2026 & 2036 (%)
- 4.6 Expanded Access
- 4.6.1 Market Size by Region, 2026-2036 (US$ Billion)
- 4.6.2 Market Share by Region, 2026 & 2036 (%)
5 Decentralised Clinical Trials Market Analysis by Indication
- 5.1 Key Findings
- 5.2 Indication Segment: Market Attractiveness Index
- 5.3 Decentralised Clinical Trials Market Size Estimation and Forecast by Indication
- 5.4 Oncology
- 5.4.1 Market Size by Region, 2026-2036 (US$ Billion)
- 5.4.2 Market Share by Region, 2026 & 2036 (%)
- 5.5 Cardiovascular
- 5.5.1 Market Size by Region, 2026-2036 (US$ Billion)
- 5.5.2 Market Share by Region, 2026 & 2036 (%)
- 5.6 Immunology
- 5.6.1 Market Size by Region, 2026-2036 (US$ Billion)
- 5.6.2 Market Share by Region, 2026 & 2036 (%)
- 5.7 Respiratory
- 5.7.1 Market Size by Region, 2026-2036 (US$ Billion)
- 5.7.2 Market Share by Region, 2026 & 2036 (%)
- 5.8 Others
- 5.8.1 Market Size by Region, 2026-2036 (US$ Billion)
- 5.8.2 Market Share by Region, 2026 & 2036 (%)
6 Decentralised Clinical Trials Market Analysis by Technology
- 6.1 Key Findings
- 6.2 Technology Segment: Market Attractiveness Index
- 6.3 Decentralised Clinical Trials Market Size Estimation and Forecast by Technology
- 6.4 Telemedicine
- 6.4.1 Market Size by Region, 2026-2036 (US$ Billion)
- 6.4.2 Market Share by Region, 2026 & 2036 (%)
- 6.5 Mobile Healthcare
- 6.5.1 Market Size by Region, 2026-2036 (US$ Billion)
- 6.5.2 Market Share by Region, 2026 & 2036 (%)
- 6.6 Wearable Devices
- 6.6.1 Market Size by Region, 2026-2036 (US$ Billion)
- 6.6.2 Market Share by Region, 2026 & 2036 (%)
- 6.7 Web-based Technology
- 6.7.1 Market Size by Region, 2026-2036 (US$ Billion)
- 6.7.2 Market Share by Region, 2026 & 2036 (%)
- 6.8 Others
- 6.8.1 Market Size by Region, 2026-2036 (US$ Billion)
- 6.8.2 Market Share by Region, 2026 & 2036 (%)
7 Decentralised Clinical Trials Market Analysis by End-User
- 7.1 Key Findings
- 7.2 End-User Segment: Market Attractiveness Index
- 7.3 Decentralised Clinical Trials Market Size Estimation and Forecast by End-User
- 7.4 Pharmaceutical and Biopharmaceutical Companies
- 7.4.1 Market Size by Region, 2026-2036 (US$ Billion)
- 7.4.2 Market Share by Region, 2026 & 2036 (%)
- 7.5 Clinical Research Organisations (CROs)
- 7.5.1 Market Size by Region, 2026-2036 (US$ Billion)
- 7.5.2 Market Share by Region, 2026 & 2036 (%)
- 7.6 Others
- 7.6.1 Market Size by Region, 2026-2036 (US$ Billion)
- 7.6.2 Market Share by Region, 2026 & 2036 (%)
8 Decentralised Clinical Trials Market Analysis by Region
- 8.1 Key Findings
- 8.2 Regional Market Size Estimation and Forecast
9 North America Decentralised Clinical Trials Market Analysis
- 9.1 Key Findings
- 9.2 North America Decentralised Clinical Trials Market Attractiveness Index
- 9.3 North America Decentralised Clinical Trials Market by Country, 2025, 2031 & 2036 (US$ Billion)
- 9.4 North America Decentralised Clinical Trials Market Size Estimation and Forecast by Country
- 9.5 North America Decentralised Clinical Trials Market Size Estimation and Forecast by Study Design
- 9.6 North America Decentralised Clinical Trials Market Size Estimation and Forecast by Indication
- 9.7 North America Decentralised Clinical Trials Market Size Estimation and Forecast by Technology
- 9.8 North America Decentralised Clinical Trials Market Size Estimation and Forecast by End-users
- 9.9 U.S. Decentralised Clinical Trials Market Analysis
- 9.10 Canada Decentralised Clinical Trials Market Analysis
10 Europe Decentralised Clinical Trials Market Analysis
- 10.1 Key Findings
- 10.2 Europe Decentralised Clinical Trials Market Attractiveness Index
- 10.3 Europe Decentralised Clinical Trials Market by Country, 2026, 2031 & 2036 (US$ Billion)
- 10.4 Europe Decentralised Clinical Trials Market Size Estimation and Forecast by Country
- 10.5 Europe Decentralised Clinical Trials Market Size Estimation and Forecast by Study Design
- 10.6 Europe Decentralised Clinical Trials Market Size Estimation and Forecast by Indication
- 10.7 Europe Decentralised Clinical Trials Market Size Estimation and Forecast by Technology
- 10.8 Europe Decentralised Clinical Trials Market Size Estimation and Forecast by End-users
- 10.9 Germany Decentralised Clinical Trials Market Analysis
- 10.10 France Decentralised Clinical Trials Market Analysis
- 10.11 UK Decentralised Clinical Trials Market Analysis
- 10.12 Italy Decentralised Clinical Trials Market Analysis
- 10.13 Spain Decentralised Clinical Trials Market Analysis
- 10.14 Russia Decentralised Clinical Trials Market Analysis
- 10.15 Poland Decentralised Clinical Trials Market Analysis
- 10.16 Belgium Decentralised Clinical Trials Market Analysis
- 10.17 Switzerland Decentralised Clinical Trials Market Analysis
- 10.18 Netherland Decentralised Clinical Trials Market Analysis
- 10.19 Rest of Europe Decentralised Clinical Trials Market Analysis
11 Asia Pacific Decentralised Clinical Trials Market Analysis
- 11.1 Key Findings
- 11.2 Asia Pacific Decentralised Clinical Trials Market Attractiveness Index
- 11.3 Asia Pacific Decentralised Clinical Trials Market by Country, 2026, 2031 & 2036 (US$ Billion)
- 11.4 Asia Pacific Decentralised Clinical Trials Market Size Estimation and Forecast by Country
- 11.5 Asia Pacific Decentralised Clinical Trials Market Size Estimation and Forecast by Study Design
- 11.6 Asia Pacific Decentralised Clinical Trials Market Size Estimation and Forecast by Indication
- 11.7 Asia Pacific Decentralised Clinical Trials Market Size Estimation and Forecast by Technology
- 11.8 Asia Pacific Decentralised Clinical Trials Market Size Estimation and Forecast by End-users
- 11.9 Japan Decentralised Clinical Trials Market Analysis
- 11.10 China Decentralised Clinical Trials Market Analysis
- 11.11 India Decentralised Clinical Trials Market Analysis
- 11.12 Australia Decentralised Clinical Trials Market Analysis
- 11.13 South Korea Decentralised Clinical Trials Market Analysis
- 11.14 Singapore Decentralised Clinical Trials Market Analysis
- 11.15 Taiwan Decentralised Clinical Trials Market Analysis
- 11.16 New Zealand Decentralised Clinical Trials Market Analysis
- 11.17 Malaysia Decentralised Clinical Trials Market Analysis
- 11.18 Rest of Asia Pacific Decentralised Clinical Trials Market Analysis
12 Latin America Decentralised Clinical Trials Market Analysis
- 12.1 Key Findings
- 12.2 Latin America Decentralised Clinical Trials Market Attractiveness Index
- 12.3 Latin America Decentralised Clinical Trials Market by Country, 2026, 2031 & 2036 (US$ Billion)
- 12.4 Latin America Decentralised Clinical Trials Market Size Estimation and Forecast by Country
- 12.5 Latin America Decentralised Clinical Trials Market Size Estimation and Forecast by Study Design
- 12.6 Latin America Decentralised Clinical Trials Market Size Estimation and Forecast by Indication
- 12.7 Latin America Decentralised Clinical Trials Market Size Estimation and Forecast by Technology
- 12.8 Latin America Decentralised Clinical Trials Market Size Estimation and Forecast by End-users
- 12.9 Brazil Decentralised Clinical Trials Market Analysis
- 12.10 Mexico Decentralised Clinical Trials Market Analysis
- 12.11 Argentina Decentralised Clinical Trials Market Analysis
- 12.12 Colombia Decentralised Clinical Trials Market Analysis
- 12.13 Chile Decentralised Clinical Trials Market Analysis
- 12.14 Rest of Latin America Decentralised Clinical Trials Market Analysis
13 MEA Decentralised Clinical Trials Market Analysis
- 13.1 Key Findings
- 13.2 MEA Decentralised Clinical Trials Market Attractiveness Index
- 13.3 MEA Decentralised Clinical Trials Market by Country, 2026, 2031 & 2036 (US$ Billion)
- 13.4 MEA Decentralised Clinical Trials Market Size Estimation and Forecast by Country
- 13.5 MEA Decentralised Clinical Trials Market Size Estimation and Forecast by Study Design
- 13.6 MEA Decentralised Clinical Trials Market Size Estimation and Forecast by Indication
- 13.7 MEA Decentralised Clinical Trials Market Size Estimation and Forecast by Technology
- 13.8 MEA Decentralised Clinical Trials Market Size Estimation and Forecast by End-users
- 13.9 GCC Decentralised Clinical Trials Market Analysis
- 13.10 South Africa Decentralised Clinical Trials Market Analysis
- 13.11 Egypt Decentralised Clinical Trials Market Analysis
- 13.12 Rest of MEA Decentralised Clinical Trials Market Analysis
14 Company Profiles
- 14.1 Competitive Landscape, 2024
- 14.2 Strategic Outlook
- 14.3 4G Clinical
- 14.3.1 Company Snapshot
- 14.3.2 Company Overview
- 14.3.3 Product Benchmarking
- 14.3.4 Strategic Outlook
- 14.4 Advarra Inc.
- 14.4.1 Company Snapshot
- 14.4.2 Company Overview
- 14.4.3 Product Benchmarking
- 14.4.4 Strategic Outlook
- 14.5 Castor
- 14.5.1 Company Snapshot
- 14.5.2 Company Overview
- 14.5.3 Solutions Benchmarking
- 14.5.4 Strategic Outlook
- 14.6 Clario
- 14.6.1 Company Snapshot
- 14.6.2 Company Overview
- 14.6.3 Solutions Benchmarking
- 14.6.4 Strategic Outlook
- 14.7 Clinical Ink
- 14.7.1 Company Snapshot
- 14.7.2 Company Overview
- 14.7.3 Solutions Benchmarking
- 14.7.4 Strategic Outlook
- 14.8 Cloudzbyz, Inc.
- 14.8.1 Company Snapshot
- 14.8.2 Company Overview
- 14.8.3 Product Benchmarking
- 14.8.4 Strategic Outlook
- 14.9 Dassault Systemes SE (Medidata Solutions, Inc.)
- 14.9.1 Company Snapshot
- 14.9.2 Company Overview
- 14.9.3 Financial Analysis
- 14.9.3.1 Net Revenue, 2021-2024
- 14.9.3.2 R&D, 2021-2024
- 14.9.3.3 Regional Market Shares, 2024
- 14.9.3.4 Business Segment Market Shares, 2024
- 14.9.4 Product Benchmarking
- 14.9.5 SWOT Analysis
- 14.9.6 Strategic Outlook
- 14.10 Ergomed Group
- 14.10.1 Company Snapshot
- 14.10.2 Company Overview
- 14.10.3 Product Benchmarking
- 14.10.4 Strategic Outlook
- 14.11 Florence Healthcare, Inc.
- 14.11.1 Company Snapshot
- 14.11.2 Company Overview
- 14.11.3 Product Benchmarking
- 14.11.4 Strategic Outlook
- 14.12 Icon Plc
- 14.12.1 Company Snapshot
- 14.12.2 Company Overview
- 14.12.3 Financial Analysis
- 14.12.3.1 Net Revenue, 2021-2024
- 14.12.3.2 Regional Market Shares, 2024
- 14.12.4 Product Benchmarking
- 14.12.5 SWOT Analysis
- 14.12.6 Strategic Outlook
- 14.13 Iqvia Inc.
- 14.13.1 Company Snapshot
- 14.13.2 Company Overview
- 14.13.3 Financial Analysis
- 14.13.3.1 Net Revenue, 2022-2025
- 14.13.3.2 Regional Market Shares, 2024
- 14.13.3.3 Business Segment Market Shares, 2025
- 14.13.4 Product Benchmarking
- 14.13.5 SWOT Analysis
- 14.13.6 Strategic Outlook
- 14.14 KORE Wireless Group, Inc.
- 14.14.1 Company Snapshot
- 14.14.2 Company Overview
- 14.14.3 Financial Analysis
- 14.14.3.1 Net Revenue, 2021-2024
- 14.14.3.2 Regional Market Shares, 2024
- 14.14.3.3 Business Segment Market Shares, 2024
- 14.14.4 Product Benchmarking
- 14.14.5 SWOT Analysis
- 14.14.6 Strategic Outlook
- 14.15 Labcorp Holdings
- 14.15.1 Company Snapshot
- 14.15.2 Company Overview
- 14.15.3 Financial Analysis
- 14.15.3.1 Net Revenue, 2022-2025
- 14.15.3.2 Regional Market Shares, 2024
- 14.15.3.3 Business Segment Market Shares, 2024
- 14.15.4 Product Benchmarking
- 14.15.5 SWOT Analysis
- 14.15.6 Strategic Outlook
- 14.16 Medable Inc.
- 14.16.1 Company Snapshot
- 14.16.2 Company Overview
- 14.16.3 Product Benchmarking
- 14.16.4 Strategic Outlook
- 14.17 Medrio, Inc.
- 14.17.1 Company Snapshot
- 14.17.2 Company Overview
- 14.17.3 Product Benchmarking
- 14.17.4 Strategic Outlook
- 14.18 Novotech Health Holdings
- 14.18.1 Company Snapshot
- 14.18.2 Company Overview
- 14.18.3 Product Benchmarking
- 14.18.4 Strategic Outlook
- 14.19 Oracle Corporation (Oracle Life Sciences)
- 14.19.1 Company Snapshot
- 14.19.2 Company Overview
- 14.19.3 Financial Analysis
- 14.19.3.1 Net Revenue, 2022-2025
- 14.19.3.2 R&D, 2022-2025
- 14.19.3.3 Regional Market Shares, 2024
- 14.19.3.4 Business Segment Market Shares, 2024
- 14.19.4 Product Benchmarking
- 14.19.5 SWOT Analysis
- 14.19.6 Strategic Outlook
- 14.20 Parexel International (MA) Corporation
- 14.20.1 Company Snapshot
- 14.20.2 Company Overview
- 14.20.3 Product Benchmarking
- 14.20.4 SWOT Analysis
- 14.20.5 Strategic Outlook
- 14.21 ProPharma Group MIS Limited
- 14.21.1 Company Snapshot
- 14.21.2 Company Overview
- 14.21.3 Product Benchmarking
- 14.21.4 Strategic Outlook
- 14.22 Science 37 Holdings, Inc.
- 14.22.1 Company Snapshot
- 14.22.2 Company Overview
- 14.22.3 Product Benchmarking
- 14.22.4 Strategic Outlook
- 14.23 Signant Health
- 14.23.1 Company Snapshot
- 14.23.2 Company Overview
- 14.23.3 Product Benchmarking
- 14.23.4 Strategic Outlook
- 14.24 Syneos Health
- 14.24.1 Company Snapshot
- 14.24.2 Company Overview
- 14.24.3 Product Benchmarking
- 14.24.4 Strategic Outlook
- 14.25 Thermo Fisher Scientific Inc.
- 14.25.1 Company Snapshot
- 14.25.2 Company Overview
- 14.25.3 Financial Analysis
- 14.25.3.1 Net Revenue, 2022-2025
- 14.25.3.2 R&D, 2022-2025
- 14.25.3.3 Regional Market Shares, 2024
- 14.25.3.4 Business Segment Market Shares, 2024
- 14.25.4 Product Benchmarking
- 14.25.5 SWOT Analysis
- 14.25.6 Strategic Outlook
- 14.26 TFS HealthScience
- 14.26.1 Company Snapshot
- 14.26.2 Company Overview
- 14.26.3 Product Benchmarking
- 14.26.4 Strategic Outlook
- 14.27 THREAD Research
- 14.27.1 Company Snapshot
- 14.27.2 Company Overview
- 14.27.3 Product Benchmarking
- 14.27.4 Strategic Outlook
- 14.28 Veeva Systems Inc.
- 14.28.1 Company Snapshot
- 14.28.2 Company Overview
- 14.28.3 Financial Analysis
- 14.28.3.1 Net Revenue, 2022-2025
- 14.28.3.2 R&D, 2021-2024
- 14.28.3.3 Regional Market Shares, 2025
- 14.28.3.4 Business Segment Market Shares, 2025
- 14.28.4 Product Benchmarking
- 14.28.5 SWOT Analysis
- 14.28.6 Strategic Outlook
15 Conclusion and Recommendations
- 15.1 Concluding Remarks from Visiongain
- 15.2 Recommendations for Market Players
Product Code: PHA1386
List of Tables
- Table 1 Decentralised Clinical Trials Market Snapshot, 2026 & 2036 (US$ Million, CAGR %)
- Table 2 Decentralised Clinical Trials Market Forecast by Region 2026-2036 (US$ Billion, AGR%, CAGR%), Tariff Impact: V- Shaped Recovery Scenario
- Table 3 Decentralised Clinical Trials Market Forecast by Region 2026-2036 (US$ Billion, AGR%, CAGR%), Tariff Impact: U- Shaped Recovery Scenario
- Table 4 Decentralised Clinical Trials Market Forecast by Region 2026-2036 (US$ Billion, AGR%, CAGR%), Tariff Impact: L- Shaped Recovery Scenario
- Table 5 Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 6 Interventional Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 7 Observational Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 8 Expanded Access Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 9 Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 10 Oncology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 11 Cardiovascular Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 12 Immunology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 13 Respiratory Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 14 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 15 Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 16 Telemedicine Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 17 Mobile Healthcare Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 18 Wearable Devices Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 19 Web-based Technology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 20 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 21 Decentralised Clinical Trials Market Forecast by End-User, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 22 Pharmaceutical and Biopharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 23 Clinical Research Organisations (CROs) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 24 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 25 Decentralised Clinical Trials Market Forecast by Region, 2026-2036 (US$ Million, AGR%, CAGR%)
- Table 26 North America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 27 North America Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 28 North America Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 29 North America Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 30 North America Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 31 U.S. Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 32 Canada Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 33 Europe Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 34 Europe Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 35 Europe Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 36 Europe Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 37 Europe Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 38 Germany Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 39 France Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 40 UK Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 41 Italy Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 42 Spain Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 43 Russia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 44 Poland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 45 Belgium Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 46 Switzerland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 47 Netherland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 48 Rest of Europe Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 49 Europe Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 50 Asia Pacific Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 51 Asia Pacific Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 52 Asia Pacific Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 53 Asia Pacific Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 54 Japan Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 55 China Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 56 India Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 57 Australia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 58 South Korea Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 59 Singapore Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 60 Taiwan Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 61 New Zealand Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 62 Malaysia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 63 Rest of Asia Pacific Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 64 Latin America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 65 Latin America Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 66 Latin America Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 67 Latin America Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 68 Latin America Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 69 Brazil Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 70 Mexico Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 71 Argentina Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 72 Colombia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 73 Chile Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 74 Rest of Latin America Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 75 Latin America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 76 MEA Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 77 MEA Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 78 MEA Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 79 MEA Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 80 GCC Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 81 South Africa Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 82 Egypt Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 83 Rest of MEA Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
- Table 84 Strategic Outlook
- Table 85 4G Clinical: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 86 4G Clinical: Product Benchmarking
- Table 87 4G Clinical: Strategic Outlook
- Table 88 Advarra Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 89 Advarra Inc.: Product Benchmarking
- Table 90 Advarra: Strategic Outlook
- Table 91 Castor: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 92 Castor: Solutions Benchmarking
- Table 93 Castor: Strategic Outlook
- Table 94 Clario: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 95 Clario: Solutions Benchmarking
- Table 96 Clario: Strategic Outlook
- Table 97 Clinical Ink: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 98 Clinical Ink: Solutions Benchmarking
- Table 99 Clinical Ink: Strategic Outlook
- Table 100 Cloudzbyz, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 101 Cloudzbyz, Inc.: Product Benchmarking
- Table 102 Cloudzbyz, Inc.: Strategic Outlook
- Table 103 Dassault Systemes SE (Medidata Solutions, Inc.): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 104 Dassault Systemes SE (Medidata Solutions, Inc.): Product Benchmarking
- Table 105 Dassault Systemes SE (Medidata Solutions, Inc.): SWOT Analysis
- Table 106 Dassault Systemes SE (Medidata Solutions, Inc.): Strategic Outlook
- Table 107 Ergomed Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 108 Ergomed Group: Product Benchmarking
- Table 109 Ergomed Group: Strategic Outlook
- Table 110 Florence Healthcare, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 111 Florence Healthcare, Inc.: Product Benchmarking
- Table 112 Florence Healthcare, Inc.: Strategic Outlook
- Table 113 Icon Plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 114 Icon Plc: Product Benchmarking
- Table 115 Icon Plc: SWOT Analysis
- Table 116 Icon Plc: Strategic Outlook
- Table 117 Iqvia Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 118 Iqvia Inc.: Product Benchmarking
- Table 119 Iqvia Inc.: SWOT Analysis
- Table 120 Iqvia Inc.: Strategic Outlook
- Table 121 KORE Wireless Group, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 122 KORE Wireless Group, Inc.: Product Benchmarking
- Table 123 KORE Wireless Group, Inc.: SWOT Analysis
- Table 124 KORE Wireless Group, Inc.: Strategic Outlook
- Table 125 Labcorp Holdings: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 126 Labcorp Holdings: Product Benchmarking
- Table 127 Labcorp Holdings: SWOT Analysis
- Table 128 Labcorp Holdings: Strategic Outlook
- Table 129 Medable Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 130 Medable Inc.: Product Benchmarking
- Table 131 Medable Inc.: Strategic Outlook
- Table 132 Medrio, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 133 Medrio, Inc.: Product Benchmarking
- Table 134 Medrio, Inc.: Strategic Outlook
- Table 135 Novotech Health Holdings: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 136 Novotech Health Holdings: Product Benchmarking
- Table 137 Novotech Health Holdings: Strategic Outlook
- Table 138 Oracle Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 139 Oracle Life Sciences: Product Benchmarking
- Table 140 Oracle Life Sciences: SWOT Analysis
- Table 141 Oracle Corporation: Strategic Outlook
- Table 142 Parexel International (MA) Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 143 Parexel International (MA) Corporation: Product Benchmarking
- Table 144 Parexel International (MA) Corporation: SWOT Analysis
- Table 145 Parexel International (MA) Corporation: Strategic Outlook
- Table 146 ProPharma Group MIS Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 147 ProPharma Group MIS Limited: Product Benchmarking
- Table 148 ProPharma Group MIS Limited: Strategic Outlook
- Table 149 Science 37 Holdings, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 150 Science 37 Holdings, Inc.: Product Benchmarking
- Table 151 Science 37 Holdings, Inc.: Strategic Outlook
- Table 152 Signant Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 153 Signant Health: Product Benchmarking
- Table 154 Signant Health: Strategic Outlook
- Table 155 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 156 Syneos Health: Product Benchmarking
- Table 157 Syneos Health: Strategic Outlook
- Table 158 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 159 Thermo Fisher Scientific Inc.: Product Benchmarking
- Table 160 Thermo Fisher Scientific Inc.: SWOT Analysis
- Table 161 Thermo Fisher Scientific Inc.: Strategic Outlook
- Table 162 TFS HealthScience: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 163 TFS HealthScience: Product Benchmarking
- Table 164 TFS HealthScience: Strategic Outlook
- Table 165 THREAD Research: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 166 THREAD Research: Product Benchmarking
- Table 167 THREAD Research: Strategic Outlook
- Table 168 Veeva Systems Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 169 Veeva Systems Inc.: Product Benchmarking
- Table 170 Veeva Systems Inc.: SWOT Analysis
- Table 171 Veeva Systems Inc.: Strategic Outlook
List of Figures
- Figure 1 Decentralised Clinical Trials Market Segmentation
- Figure 2 Decentralised Clinical Trials Market by Study-Design: Market Attractiveness Index
- Figure 3 Decentralised Clinical Trials Market by Indication: Market Attractiveness Index
- Figure 4 Decentralised Clinical Trials Market by Technology: Market Attractiveness Index
- Figure 5 Decentralised Clinical Trials Market by End-users: Market Attractiveness Index
- Figure 6 Decentralised Clinical Trials Market by Region: Market Attractiveness Index
- Figure 7 Decentralised Clinical Trials Market: Market Dynamics
- Figure 8 Decentralised Clinical Trials Market: Impact Analysis
- Figure 9 Decentralised Clinical Trials Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: V-Shaped Recovery Scenario
- Figure 10 Decentralised Clinical Trials Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
- Figure 11 Decentralised Clinical Trials Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
- Figure 12 Short Term & Long Term Planning
- Figure 13 Impact of U.S. and China Trade War
- Figure 14 Most Impacted Countries
- Figure 15 Decentralised Clinical Trials Market: Porter's Five Forces Analysis
- Figure 16 Decentralised Clinical Trials Market: PEST Analysis
- Figure 17 Decentralised Clinical Trials Market by Study Design: Market Attractiveness Index
- Figure 18 Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
- Figure 19 Decentralised Clinical Trials Market Share Forecast by Study Design, 2026, 2031, 2036 (%)
- Figure 20 Interventional Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 21 Interventional Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 22 Observational Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 23 Observational Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 24 Expanded Access Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 25 Expanded Access Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 26 Decentralised Clinical Trials Market by Indication: Market Attractiveness Index
- Figure 27 Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
- Figure 28 Decentralised Clinical Trials Market Share Forecast by Indication, 2026, 2031, 2036 (%)
- Figure 29 Oncology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 30 Oncology Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 31 Cardiovascular Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 32 Cardiovascular Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 33 Immunology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 34 Immunology Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 35 Respiratory Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 36 Respiratory Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 37 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 38 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 39 Decentralised Clinical Trials Market by Technology: Market Attractiveness Index
- Figure 40 Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
- Figure 41 Decentralised Clinical Trials Market Share Forecast by Technology, 2026, 2031, 2036 (%)
- Figure 42 Telemedicine Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 43 Telemedicine Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 44 Mobile Healthcare Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 45 Mobile Healthcare Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 46 Wearable Devices Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 47 Wearable Devices Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 48 Web-based Technology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 49 Web-based Technology Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 50 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 51 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 52 Decentralised Clinical Trials Market by End-User: Market Attractiveness Index
- Figure 53 Decentralised Clinical Trials Market Forecast by End-User, 2026-2036 (US$ Billion, AGR %)
- Figure 54 Decentralised Clinical Trials Market Share Forecast by End-User, 2026, 2031, 2036 (%)
- Figure 55 Pharmaceutical and Biopharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 56 Pharmaceutical and Biopharmaceutical Companies Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 57 Clinical Research Organisations (CROs) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 58 Clinical Research Organisations (CROs) Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 59 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 60 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
- Figure 61 Decentralised Clinical Trials Market Forecast by Region 2025 and 2036 (Revenue, CAGR%)
- Figure 62 Decentralised Clinical Trials Market Share Forecast by Region 2026, 2031, 2036 (%)
- Figure 63 Decentralised Clinical Trials Market by Region, 2026-2036 (US$ Billion, AGR %)
- Figure 64 North America Decentralised Clinical Trials Market Attractiveness Index
- Figure 65 North America Decentralised Clinical Trials Market by Region, 2025, 2031 & 2036 (US$ Billion)
- Figure 66 North America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
- Figure 67 North America Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
- Figure 68 North America Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
- Figure 69 North America Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
- Figure 70 North America Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
- Figure 71 North America Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
- Figure 72 North America Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
- Figure 73 North America Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
- Figure 74 North America Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
- Figure 75 North America Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
- Figure 76 U.S. Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 77 Canada Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 78 Europe Decentralised Clinical Trials Market Attractiveness Index
- Figure 79 Europe Decentralised Clinical Trials Market by Region, 2026, 2031 & 2036 (US$ Billion)
- Figure 80 Europe Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
- Figure 81 Europe Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
- Figure 82 Europe Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
- Figure 83 Europe Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
- Figure 84 Europe Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
- Figure 85 Europe Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
- Figure 86 Europe Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
- Figure 87 Europe Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
- Figure 88 Europe Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
- Figure 89 Europe Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
- Figure 90 Germany Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 91 France Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 92 UK Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 93 Italy Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 94 Spain Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 95 Russia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 96 Poland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 97 Belgium Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 98 Switzerland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 99 Netherland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 100 Rest of Europe Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 101 Asia Pacific Decentralised Clinical Trials Market Attractiveness Index
- Figure 102 Asia Pacific Decentralised Clinical Trials Market by Region, 2026, 2031 & 2036 (US$ Billion)
- Figure 103 Asia Pacific Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
- Figure 104 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
- Figure 105 Asia Pacific Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
- Figure 106 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
- Figure 107 Asia Pacific Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
- Figure 108 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
- Figure 109 Asia Pacific Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
- Figure 110 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
- Figure 111 Asia Pacific Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
- Figure 112 Asia Pacific Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
- Figure 113 Japan Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 114 China Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 115 India Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 116 Australia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 117 South Korea Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 118 Singapore Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 119 Taiwan Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 120 New Zealand Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 121 Malaysia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 122 Rest of Asia Pacific Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 123 Latin America Decentralised Clinical Trials Market Attractiveness Index
- Figure 124 Latin America Decentralised Clinical Trials Market by Region, 2026, 2031 & 2036 (US$ Billion)
- Figure 125 Latin America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
- Figure 126 Latin America Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
- Figure 127 Latin America Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
- Figure 128 Latin America Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
- Figure 129 Latin America Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
- Figure 130 Latin America Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
- Figure 131 Latin America Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
- Figure 132 Latin America Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
- Figure 133 Latin America Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
- Figure 134 Latin America Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
- Figure 135 Brazil Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 136 Mexico Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 137 Argentina Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 138 Colombia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 139 Chile Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 140 Rest of Latin America Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 141 MEA Decentralised Clinical Trials Market Attractiveness Index
- Figure 142 MEA Decentralised Clinical Trials Market by Region, 2026, 2031 & 2036 (US$ Billion)
- Figure 143 MEA Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
- Figure 144 MEA Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
- Figure 145 MEA Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
- Figure 146 MEA Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
- Figure 147 MEA Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
- Figure 148 MEA Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
- Figure 149 MEA Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
- Figure 150 MEA Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
- Figure 151 MEA Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
- Figure 152 MEA Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
- Figure 153 GCC Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 154 South Africa Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 155 Egypt Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 156 Rest of MEA Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
- Figure 157 Decentralised Clinical Trials Market: Company Share/Ranking, 2024
- Figure 158 Dassault Systemes SE (Medidata Solutions, Inc.): Net Revenue, 2021-2024 (US$ Million, AGR%)
- Figure 159 Dassault Systemes SE (Medidata Solutions, Inc.): R&D, 2021-2024 (US$ Million, AGR%)
- Figure 160 Dassault Systemes SE (Medidata Solutions, Inc.): Regional Market Shares, 2024
- Figure 161 Dassault Systemes SE (Medidata Solutions, Inc.): Business Segment Market Shares, 2024
- Figure 162 Icon Plc: Net Revenue, 2021-2024 (US$ Million, AGR%)
- Figure 163 Icon Plc: Regional Market Shares, 2024
- Figure 164 Iqvia Inc.: Net Revenue, 2022-2025 (US$ Million, AGR%)
- Figure 165 Iqvia Inc.: Regional Market Shares, 2024
- Figure 166 Iqvia Inc.: Business Segment Market Shares, 2025
- Figure 167 KORE Wireless Group, Inc.: Net Revenue, 2021-2024 (US$ Million, AGR%)
- Figure 168 KORE Wireless Group, Inc.: Regional Market Shares, 2024
- Figure 169 KORE Wireless Group, Inc.: Business Segment Market Shares, 2024
- Figure 170 Labcorp Holdings: Net Revenue, 2022-2025 (US$ Million, AGR%)
- Figure 171 Labcorp Holdings: Regional Market Shares, 2024
- Figure 172 Labcorp Holdings: Business Segment Market Shares, 2024
- Figure 173 Oracle Life Sciences: Net Revenue, 2022-2025 (US$ Million, AGR%)
- Figure 174 Oracle Life Sciences: R&D, 2022-2025 (US$ Million, AGR%)
- Figure 175 Oracle Life Sciences: Regional Market Shares, 2025
- Figure 176 Oracle Life Sciences: Business Segment Market Shares, 2025
- Figure 177 Thermo Fisher Scientific Inc.: Net Revenue, 2022-2025 (US$ Million, AGR%)
- Figure 178 Thermo Fisher Scientific Inc.: R&D, 2022-2025 (US$ Million, AGR%)
- Figure 179 Thermo Fisher Scientific Inc.: Regional Market Shares, 2024
- Figure 180 Thermo Fisher Scientific Inc.: Business Segment Market Shares, 2024
- Figure 181 Veeva Systems Inc.: Net Revenue, 2022-2025 (US$ Million, AGR%)
- Figure 182 Veeva Systems Inc.: R&D, 2022-2025 (US$ Million, AGR%)
- Figure 183 Veeva Systems Inc.: Regional Market Shares, 2025
- Figure 184 Veeva Systems Inc.: Business Segment Market Shares, 2025
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.